Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.25.639957

Hepatic Metabolic Memory Triggered by AM Exposure to Glucagon Alters Afternoon Glucose Metabolism

Abstract

The Staub-Traugott effect, or second-meal phenomenon, describes improved glucose disposal after a second identical meal. We previously showed that morning hyperinsulinemia primes the liver to enhance afternoon net hepatic glucose uptake and glycogen storage. However, mixed meals trigger co-secretion of insulin and glucagon, and glucagon is traditionally viewed as opposing insulins hepatic actions. Whether glucagon modifies the persistence of insulins priming effects across sequential metabolic challenges is unknown. Therefore, we investigated whether morning hyperglucagonemia alters the ability of morning hyperinsulinemia to prime subsequent hepatic glucose metabolism. Conscious dogs underwent two pancreatic clamp periods separated by a 1.5h rest period. Endogenous insulin and glucagon were suppressed with somatostatin and replaced intraportally at defined rates. During a 4h morning hyperinsulinemic-euglycemic clamp, dogs received matched insulin prime infusions with either basal glucagon (AM INS; n=8) or elevated glucagon (AM INS+GCG; n=8). After the rest period, both groups underwent a 2.5h afternoon hyperinsulinemic-hyperglycemic clamp under identical hormonal conditions. Afternoon net hepatic glucose uptake, glycogen, glycolytic, and gluconeogenic flux rates were quantified using arteriovenous difference methods and [3-3H]-glucose tracer kinetics. Liver biopsies were collected before and after the afternoon clamp to assess gene transcription and protein regulators of hepatic glucose metabolism. During the afternoon clamp, despite matched insulin, glucagon, and glucose levels, net hepatic glucose uptake was 41% lower in AM INS+GCG (3.6{+/-}0.4 mg/kg/min) than in AM INS (6.1{+/-}0.6 mg/kg/min; p<0.003). This was accompanied by a trend toward incomplete suppression of hepatic glucose production in AM INS+GCG (1.4{+/-}0.4 mg/kg/min), whereas it was fully suppressed in the AM INS group (p=0.06). Direct glycogen synthesis was also 44% lower in AM INS+GCG (1.8{+/-}0.2 vs 3.2{+/-}0.7 mg/kg/min; p<0.015), along with reductions in net glycogen synthesis and glycolytic flux. Morning insulin with basal glucagon increased hepatic glucokinase mRNA and protein before the afternoon clamp, whereas concurrent glucagon prevented this induction. In summary, antecedent morning hyperglucagonemia attenuates insulin-mediated hepatic priming, reducing hepatic glucose flux during a later hyperinsulinemic-hyperglycemic challenge. These findings identify glucagon as a regulator of hepatic metabolic memory alongside insulin and demonstrate that early-day insulin-glucagon dynamics shape the livers response to subsequent challenges, providing mechanistic insight into postprandial glucose regulation and implications for metabolic health and diabetes risk. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=121 SRC="FIGDIR/small/639957v3_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@6d210org.highwire.dtl.DTLVardef@1c93840org.highwire.dtl.DTLVardef@18c0b49org.highwire.dtl.DTLVardef@138ee9f_HPS_FORMAT_FIGEXP M_FIG C_FIG

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Waterman, H. L., Smith, M., Farmer, B., Yankey, K., Howard, T., Kraft, G., Edgerton, D., Cherrington, A.. 2025-02-28. Hepatic Metabolic Memory Triggered by AM Exposure to Glucagon Alters Afternoon Glucose Metabolism. https://doi.org/10.1101/2025.02.25.639957

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗